MARKET

LIFE

LIFE

aTyr Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.660
-0.020
-0.54%
After Hours: 3.670 +0.01 +0.27% 17:10 05/17 EDT
OPEN
3.610
PREV CLOSE
3.680
HIGH
3.830
LOW
3.559
VOLUME
119.56K
TURNOVER
--
52 WEEK HIGH
8.33
52 WEEK LOW
2.930
MARKET CAP
58.60M
P/E (TTM)
-2.3204
1D
5D
1M
3M
1Y
5Y
Love Hemp Group PLC Announces Exercise of Warrants and Issue of Equity
ACCESSWIRE · 8h ago
Atyr Pharma (LIFE) Reports Q1 Loss, Lags Revenue Estimates
Atyr Pharma (LIFE) delivered earnings and revenue surprises of -50.00% and -100.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 4d ago
BRIEF-Atyr Pharma Announces First Quarter 2021 Results And Provides Corporate Update
reuters.com · 4d ago
aTyr Pharma EPS misses by $0.19
aTyr Pharma (LIFE): Q1 GAAP EPS of -$0.51 misses by $0.19.Ended the quarter with $50.6 million in cash, cash equivalents and investments.Shares +21%.Press Release
Seekingalpha · 4d ago
aTyr Pharma, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / aTyr Pharma, Inc. (NASDAQ:LIFE) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 5:00 PM Eastern Time.
ACCESSWIRE · 4d ago
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12)
Benzinga · 4d ago
Earnings Scheduled For May 13, 2021
  Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.
Benzinga · 4d ago
BRIEF-aTyr Pharma And Its Hong Kong Subsidiary, Pangu Biopharma, Achieve Milestones For First Year Of Government Grant To Develop Bispecific Antibody Platform
reuters.com · 5d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LIFE. Analyze the recent business situations of aTyr Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LIFE stock price target is 16.25 with a high estimate of 20.00 and a low estimate of 13.00.
EPS
Institutional Holdings
Institutions: 43
Institutional Holdings: 6.46M
% Owned: 40.35%
Shares Outstanding: 16.01M
TypeInstitutionsShares
Increased
6
334.67K
New
2
156
Decreased
1
77.17K
Sold Out
2
332.27K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.79%
Pharmaceuticals & Medical Research
+0.65%
Key Executives
Chairman/Independent Director
John Clarke
President/Chief Executive Officer/Director
Sanjay Shukla
Chief Financial Officer
Jill Broadfoot
General Counsel/Secretary
Nancy Krueger
General Counsel/Secretary
Nancy Denyes
Independent Director
Timothy Coughlin
Independent Director
Jane Gross
Independent Director
Jeffrey Hatfield
Independent Director
Svetlana Lucas
Independent Director
Paul Schimmel
No Data
About LIFE
aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.

Webull offers kinds of aTyr Pharma Inc stock information, including NASDAQ:LIFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LIFE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LIFE stock methods without spending real money on the virtual paper trading platform.